Table 5.

Percentage change in crude prevalence of Cataract MSVI (presenting visual acuity <6/18, ≥3/60) and in adults aged 50 years and older between 2000 and 2020 by world super region.

	Crude prevalence			Number of cases (‘000 s)			Age standardized prevalence
World Region	Male (%, 95% UI)	Female (%, 95% UI)	Both (%, 95% UI)	Male (%, 95% UI)	Female (%, 95% UI)	Both (%, 95% UI)	Male (%, 95% UI)	Female (%, 95% UI)	Both (%, 95% UI)
Global	9.82 (9.61–10.03)	9.70 (9.50–9.89)	9.72 (9.52–9.92)	93.69 (93.32–94.05)	92.70 (92.36–93.04)	93.11 (92.75–93.46)	4.70 (4.52–4.89)	8.94 (8.75–9.13)	7.17 (6.98–7.36)
High-income	20.98 (20.74–21.23)	9.66 (9.44–9.88)	12.62 (12.40–12.84)	78.04 (77.67–78.40)	52.75 (52.45–53.05)	60.90 (60.58–61.21)	1.56 (1.36–1.76)	0.02 (−0.18–0.21)	−0.48 (−0.67–−0.28)
Central Europe, Eastern Europe, and Central Asia	12.39 (12.13–12.66)	9.21 (8.96–9.46)	9.52 (9.27–9.77)	45.79 (45.45–46.13)	35.12 (34.81–35.42)	38.18 (37.87–38.49)	0.96 (0.74–1.17)	1.33 (1.11–1.55)	0.46 (0.24–0.68)
Latin America and Caribbean	−0.64 (−0.83–−0.44)	2.41 (2.22–2.61)	1.11 (0.91–1.31)	95.81 (95.42–96.19)	109.62 (109.21–110.02)	103.30 (102.91–103.70)	−5.59 (−5.77–−5.41)	−4.22 (−4.40–−4.04)	−4.83 (−5.01–−4.65)
North Africa and Middle East	−6.92 (−7.11–−6.73)	−3.43 (−3.62–−3.24)	−5.00 (−5.19–−4.81)	93.39 (92.99–93.78)	100.96 (100.57–101.35)	97.53 (97.14–97.92)	−1.03 (−1.22–−0.84)	−2.89 (−3.07–−2.71)	−1.92 (−2.10–−1.73)
South Asia	0.83 (0.64–1.02)	−3.41 (−3.59–−3.23)	−1.14 (−1.33–−0.96)	90.29 (89.93–90.65)	95.27 (94.91–95.63)	93.04 (92.68–93.40)	−3.46 (−3.63–−3.29)	−7.64 (−7.80–−7.48)	−5.53 (−5.69–−5.37)
Southeast Asia, East Asia, and Oceania	8.65 (8.45–8.85)	5.62 (5.43–5.80)	7.12 (6.93–7.31)	114.84 (114.44–115.24)	115.45 (115.07–115.83)	115.21 (114.83–115.58)	−0.70 (−0.87–−0.53)	3.53 (3.36–3.70)	1.96 (1.78–2.13)
Sub-Saharan Africa	−6.04 (−6.22–−5.87)	−0.15 (−0.33–0.03)	−2.29 (−2.47–−2.11)	66.22 (65.91–66.53)	93.70 (93.35–94.04)	81.29 (80.96–81.62)	−0.60 (−0.78–−0.43)	4.70 (4.52–4.88)	2.29 (2.12–2.47)